구절초 꽃 추출물의 Nitric Oxide 생성과 Inducible Nitric Oxide Synthase 발현 억제 효과

국문 초록 (Abstract)

본 연구에서는 구절초의 항염증 효과를 탐색하기 위해 NO의 함량과 iNOS의 발현 및 PGE2와 COX-2의 발현을 LPS로 염증을 유도한 RAW 264.7 macrophage cell을 이용하여 실험하였다. 연구 결과 구절초 꽃 추출물은 NO 함량을 농도 의존적으로 감소시키는 경향을 나타냈으며 유의한 차이를 보였다. 또한 세포독성은 꽃 추출물(5～50 ㎍/mL)은 최고 농도인 50 ㎍/mL에서 약 20%의 독성을 나타냈으며 그 이하의 농도에서는 독성을 나타내지 않았다. NO 생성의 억제는 iNOS의 단백질과 mRNA의 발현을 농도 의존적으로 저해하였으며 유의성 있는 차이를 나타내었다. 이 결과로 구절초 꽃 추출물이 전사단계에서 저해 활성을 나타낸다는 것을 보여주었다. 그러나 PGE2와 COX-2의 발현 억제 효과는 나타나지 않았으며, 이 결과 구절초 꽃 추출물에 의한 COX-2 단백질의 발현 억제와 PGE2 생성 억제는 유의성이 없는 것으로 나타났다. 본 연구 결과, 구절초 추출물은 염증을 일으키는 중요 인자인 NO를 저해하였고, iNOS의 발현, iNOS의 mRNA 발현 등 항염증에 우수한 효과를 보였으며, 항염증 연구의 기초 자료로 활용될 것으로 예상된다. 또한 추후 산업적 응용도 가능하므로 지속적인 연구가 진행되어야 할 것으로 사료된다.

다국어 초록 (Multilingual Abstract)

In this study, we investigated the effect of C. zawadskii extract on nitric oxide (NO) production, prostaglandin E2 (PGE2) production, protein and mRNA expression of inducible nitric oxide synthase (iNOS) in LPS-induced RAW 264.7 macrophage cells. C. zawadskii extract (5~50 ㎍/mL) significantly inhibited LPS-induced NO production in a concentration-dependent manner ranging from 23.3% to 100%. Consistent with the inhibitory effect on NO production, C. zawadskii extract inhibited the protein expression and mRNA expression of iNOS. Although flower extracts of C. zawadskii was not effective on the expression of PGE2 and COX-2, flower extracts of C. zawadskii, however, showed a strong anti-inflammatory activity through inhibition of NO production and iNOS expression. The present results suggest that C. zawadskii extract has an inhibitory effect on NO production, and thus can be used as an anti-inflammatory agent.

목차 (Table of Contents)

• Abstract
• 서론
• 재료 및 방법
• 결과 및 고찰
• 요약
• 감사의 글
• 문헌

참고문헌 (Reference)

1 임록재, "조선약용식물지" 농업출판사 186-, 1998

2 원도희, "약용식물도감" 식품의약품안전본부 72-, 1997

3 육창수, "생약도감" 도서출판 경원 528-, 1997

4 이창복, "대한식물도감" 향문사 754-, 1982

5 Lee MH, "he anti-inflammatory effects of Pyrolae herva extract through the inhibition of the expression of inducible nitric oxide synthase (iNOS) and NO production" 112 : 49-54, 2007

6 Lee HJ, "generation in murine" 32 : 173-180, 2006

7 Vodovotz Y, "Vesicle membrane association of nitric oxide synthase in primary mouse macrophage" 154 : 2914-2925, 1995

8 Bredt DS, "Transient nitric oxide synthase neurons in embryonic cerebral cortical plate, sensory ganglia, and olfactory epithelium" 13 : 301-313, 1994

9 Jung KH, "Suppressive effects of nitric oxide (NO) production and inducible nitric oxide synthase (iNOS) expression by Citrus reticulata extract in RAW 264.6 macrophage cells" 45 : 1545-1550, 2007

10 Bae IK, "Suppression of lipopolysaccharide-induced expression of inducible nitric oxide synthase by brazilin in RAW 264.7 macrophage cells" 513 : 237-242, 2005

11 Chun KS, "Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention" 15 : 1089-1100, 2004

12 Kim JH, "Rengyolone inhibits inducible nitric oxide synthase expression and nitric oxide production by down- regulation of NF-κB and p38 MAP kinase activity in LPS-stimulated RAW 264.7 cells" 71 : 1198-1205, 2006

13 Hirafuji M, "Reduced expressions of inducible nitric oxide synthase and cyclooxygenase-2 in smooth muscle cells of stroke-prone spontaneously hypertensive rats" 70 : 917-926, 2002

14 전용필, "RAW 264.7세포에서 lipopolysaccharide로 유발시킨 염증반응에 대한 Bulnesia sarmienti 열수추출물의 억제효과" 한국생명과학회 19 (19): 479-485, 2009

15 Jaffrey SR, "Nitric oxide: a neural messenger" 11 : 417-440, 1995

16 Garcia X, "Nitric oxide" 17 : 55-57, 2006

17 Sarkar D, "Molecular mechanisms of aging-associated inflammation" 236 : 13-23, 2006

18 Fierro IM, "Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin- triggered lipoxins" 34 : 555-566, 2001

19 Lowenstein CJ, "Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide" 90 : 9730-9734, 1993

20 장선일, "LPS로 활성화된 U937 세포에서 Prostaglandin E2 (PGE2) 생성 및 Cyclooxygenase-2 (COX-2) 활성 억제에 대한 한약제의 평가" 대한동의병리학회 20 (20): 455-459, 2006

21 Pacheco-Sanchez M, "Inhibitory effects of CDP, a polysaccharide extracted from the mushroom Collybia dryophila, on nitric oxide synthase expression and nitric oxide production in macrophage" 555 : 61-66, 2007

22 Lee SH, "Inhibitory effect of 2'-hydrozycinnamaldehyde on nitric oxide production through inhibition of NF-κB activation in RAW 264.7 cells" 69 : 791-799, 2005

23 Tsao LT, "Inhibition of lipopolysaccharide-stimulated nitric oxide production in RAW 264.7 macrophages by a synthetic carbazole, LCY-2-CHO" 63 : 1961-1968, 2002

24 Kang OH, "Ethyl acetate extract from Angelica Dahuricae Radix inhibits lipopolysaccharide-induced production of nitric oxide, prostaglandin E2 and tumor necrosis factor-α via mitogen-activated protein kinase and nuclear factor-κB in macrophages" 55 : 263-270, 2007

25 Smith WL, "Cyclooxygenase: structures, cellular, and molecular biology" 69 : 145-182, 2000

26 Ukiya M, "Constituents of Compositae plants. 2. Triterpene dio, triol, and their 3-O-fatty acid esters from edible Chrysanthemum flower extract and their anti-inflammatory effects" 49 : 3187-3197, 2001

27 Cheon MS, "Chrysanthemum indicum Linne extract inhibits the inflammatory response by suppressing NK-κB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophages" 112 : 473-477, 2009

28 Kim YY, "Biological activities of linarin from Chrysanthemum zawadskii var. latilobum" 45 : 604-610, 2001

29 Hseu YC, "Anti-inflammatory potential of Antrodia camphorata through inhibition of iNOS, COX-2 and cytokines via the NF-κB pathway" 5 : 1914-1925, 2005

30 Park JS, "Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways" 7 : 70-77, 2007